Month: March 2022

FY 2021 End of Period Subscribers of 4.2 millionQ4 2021 Revenues of $276 millionFY 2021 Revenues of $1.2 billionQ4 2021 Gross Margin of 61.2%; excluding one-time charges, Q4 2021 adjusted gross margin of 61.3%FY 2021 Gross Margin of 59.9%; excluding one-time charges, FY 2021 adjusted gross margin increased 300 basis points year-over-year to 61.2%Q4 2021 Operating Income of $54 million; excluding one-time charges, Q4 2021 adjusted operating income of $55 millionFY 2021 Operating Income of $196 million; excluding one-time charges, FY 2021 adjusted operating income of $216 millionQ1 2022 Guidance: Revenues of approximately $300 million and net loss per share in the range of $0.26 to $0.31As previously announced, Sima Sistani, Co-Founder and former CEO of Houseparty and a senior leader at Epic Games, to join WW as CEO on...

Fiscal Year 2021 Revenue Up 67% Year-Over-Year to $247 MillionFourth Quarter 2021 Revenue Up 107% Year-Over-Year to $95.7 Million LOS ANGELES, March 01, 2022 (GLOBE NEWSWIRE) — PLBY Group, Inc. (NASDAQ: PLBY) (“PLBY Group” or the “Company”), a leading pleasure and leisure lifestyle company and owner of Playboy, one of the most recognizable and iconic brands in the world, today provided preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2021. “2021 was a stellar year for our company, with $247 million in annual revenue, three acquisitions, the launch of our digital blockchain products and Centerfold platform, and great momentum behind our transformation from a legacy media company to a direct-to-consumer and digital business model,” said PLBY Group’s Chief Executive Officer Ben Kohn....

Record Fiscal 2021 Full Year EPS of $4.55 and Fourth Quarter EPS of $0.89 Ends Fiscal 2021 with $97.4 Million in Cash and Cash Equivalents, No Debt Delivers Over $69 Million of Capital to Shareholders through Dividends and Stock Repurchases in Fiscal 2021 Declares Regular Quarterly Cash Dividend of $0.25 per shareEL SEGUNDO, Calif., March 01, 2022 (GLOBE NEWSWIRE) — Big 5 Sporting Goods Corporation (Nasdaq: BGFV) (the “Company,” “we,” “our,” “us,” “Big 5”), a leading sporting goods retailer, today reported financial results for the fiscal 2021 fourth quarter and full year ended January 2, 2022. Steven G. Miller, the Company’s Chairman, President and Chief Executive Officer, said, “Our fourth quarter performance capped off a second consecutive record year of sales and earnings. In addition to strong top line sales, our 2021 results...

KORSUVA™ (difelikefalin) injection U.S. commercial launch on track for April 2022 with extensive pre-launch activities completed Initiation of Oral KORSUVA (difelikefalin) Phase 3 pruritus programs in non-dialysis dependent advanced chronic kidney disease and atopic dermatitis expected in 1Q 2022 Phase 3 programs to be highlighted in virtual R&D event on March 11, 2022 at 1:00 pm ET Conference call today at 4:30 p.m. ET STAMFORD, Conn., March 01, 2022 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq: CARA), an early commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced financial results and operational highlights for the fourth quarter and full year ended December 31, 2021. “Cara Therapeutics made excellent progress in 2021 executing...

Conference Call at 4:30 pm ET Today BURNABY, British Columbia, March 01, 2022 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today reported financial results for the year ended December 31, 2021 and provided a corporate update. Mr. Ian Mortimer, Xenon’s President and Chief Executive Officer stated, “We made significant progress in 2021, marked by the positive read-out of strong efficacy data from our XEN1101 Phase 2b X-TOLE clinical trial, which represented a transformative event for Xenon. We have successfully carried this positive momentum into 2022 as we look forward to an end-of-Phase 2 meeting with the FDA in the second quarter and continue to focus on initiation of Phase 3 development for XEN1101 in the second half of 2022. In addition, we have now filed an IND...

NEW YORK and VIENNA, Austria, March 01, 2022 (GLOBE NEWSWIRE) — HOOKIPA Pharma Inc. (Nasdaq: HOOK), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced that it intends to offer and sell shares of its common stock and shares of its non-voting Series A convertible preferred stock in an underwritten public offering (the “Offering”). HOOKIPA also intends to grant the underwriters a 30-day option to purchase up to an additional fifteen percent (15%) of the shares of common stock offered in the Offering, including the shares of common stock underlying the non-voting Series A convertible preferred stock. The Offering is subject to market and other conditions, and there can be no assurance as to whether or when the Offering may be completed, or as to the size or terms of...

CALGARY, Alberta, March 01, 2022 (GLOBE NEWSWIRE) — Eguana Technologies Inc. (“Eguana” or the “Company“) (TSX-V: EGT, OTCQB: EGTYF) today announced results for its first fiscal quarter ended December 31, 2021. “Launching our first premium brand into the market has delivered an outcome beyond our expectation with immediate order uptake right out of the gate,” commented Eguana CEO Justin Holland. “Our sales teams are rapidly expanding distribution channels with multiple national players to ensure easy access to products throughout the US and we have expedited the transition to Omega to increase our manufacturing and supply chain capabilities.” Fiscal Q1 2022 Financial HighlightsQ1 2022 product revenue of $1.3 million, down from Q1 2021 product revenue of $2.3 million due to the global resin shortage, impacting...

Divestiture of the KCS line to CN would increase competition by enhancing shipping options for many local businesses, while solving CP-KCS’s parallel track conflict and preventing an important freight corridor from declining due to a lack of investment by CP-KCS CN will invest in the Kansas City Speedway, which will benefit customers and communities, create union and management jobs, and produce substantial environmental benefits by taking 80,000 trucks off the road annually MONTREAL, March 01, 2022 (GLOBE NEWSWIRE) — CN (TSX: CNR, NYSE: CNI) yesterday filed a responsive application with the Surface Transportation Board (“STB”) requesting specific conditions related to the approval of the pending Canadian Pacific (“CP”) and Kansas City Southern (“KCS”) merger (collectively “CP-KCS”). CN’s responsive application asks the STB to...

BURLINGTON, Mass., March 01, 2022 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in four upcoming investor conferences in March. 34th Annual Roth Conference 2022Monday, March 14, 2022The Ritz Carlton, Laguna Niguel located in Dana Point, CADavid Roberts, President, will present at 1:30 PM PT (4:30pm ET) Oppenheimer 32nd Annual Healthcare Conference (Virtual)Wednesday, March 16, 2022JJ Pellegrino, Chief Financial Officer, will present at 4:40 PM ET Barclays Global Healthcare ConferenceThursday, March 17, 2022Loews Miami Beach Hotel, Miami Beach, FLDavid Roberts, President, will present at 10:15 AM ET KeyBanc Life Sciences & MedTech Investor Forum (Virtual)Tuesday, March 22, 2022David Roberts, President, will present at 2:15 PM ET About LeMaitreLeMaitre is a provider...

TORONTO, March 01, 2022 (GLOBE NEWSWIRE) — iSIGN Media Solutions Inc. (“iSIGN” or “Company”) (TSX-V: ISD) (OTC: ISDSF), a leading provider of interactive mobile proximity marketing and public security alert solutions announced that it received final approval from the necessary regulatory agency to close its previously announced debt settlement arrangement (“Arrangement”) with a company in which Josip (Joe) Kozar is a major shareholder. This shares for debt transaction is the second step in improving the Company’s Statements of Financial Position. The first step was the acceptance by various creditors to transfer current liabilities of approximately $3.241 million new two-year debentures (the “New Debentures”) bearing interest at 12% per annum, as announced on February 16, 2022. This agreement provides clarity and repayment certainty...